Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the ...

In lupus the CAR-T cells are modified not to target cancer, but instead a different type of immune cell called the B cell.

At the time when patients with lupus, or systemic lupus erythematosus (SLE), are diagnosed, approximately 15% to 30% will ...

In a surprising discovery, scientists found that lupus symptoms often decline with age due to a natural reduction in immune ...

Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are still trying to figure out why. One reason may be related to the number of X ...

Medically reviewed by Scott J. Zashin, MD Rheumatoid arthritis and lupus (systemic lupus erythematosus) are both autoimmune conditions that can cause fatigue, pain and swelling in your joints, and ...

Systemic Lupus Erythematosus: Which Drugs and When? Ronald F van Vollenhoven Disclosures Int J Clin Rheumatol. 2014;9 (4):385-394. Short-term Treatment of Active Nonrenal SLE ...

Adults exposed to higher levels of PM2.5 have an elevated risk of developing systemic lupus erythematosus, a study finds.

This week, the American College of Rheumatology (ACR) released updated guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. The new ...

Northwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus ...